State Targets Treatment for Trans Youths
The Florida Department of Health on Wednesday released guidance that said treatment such as puberty-blocking medication and hormone therapy should…
April 21, 2022 at 07:10 PM
4 minute read
State and Local GovernmentThe Florida Department of Health on Wednesday released guidance that said treatment such as puberty-blocking medication and hormone therapy should not be used for transgender youths, clashing with federal officials over the issue.
The guidance came amid debates in other states about such treatment and is the latest move by Gov. Ron DeSantis' administration and Republican leaders to target transgender issues. As an example, DeSantis last month signed a controversial law that restricts instruction about gender identity and sexual orientation in public schools.
A news release from the Department of Health said the guidance addresses treatment of gender dysphoria, which the federal government defines as clinically "significant distress that a person may feel when sex or gender assigned at birth is not the same as their identity."
The state news release said "current evidence does not support the use of puberty blockers, hormone treatments or surgical procedures for children and adolescents." Florida Surgeon General Joseph Ladapo also issued a statement blasting federal directives that backed treatment for transgender youths.
"It was about injecting political ideology into the health of our children," Ladapo said. "Children experiencing gender dysphoria should be supported by family and seek counseling, not pushed into an irreversible decision before they reach 18."
But the U.S. Department of Health and Human Services last month issued guidance that said its Office for Civil Rights "will continue working to ensure that transgender and gender nonconforming youth are able to access health care free from the burden of discrimination."
"The Department of Health & Human Services stands with transgender and gender nonconforming youth and their families — and the significant majority of expert medical associations — in unequivocally stating that gender affirming care for minors, when medically appropriate and necessary, improves their physical and mental health," the federal agency's statement said. "Attempts to restrict, challenge or falsely characterize this potentially lifesaving care as abuse is dangerous. Such attempts block parents from making critical health care decisions for their children, create a chilling effect on health care providers who are necessary to provide care for these youth, and ultimately negatively impact the health and well-being of transgender and gender nonconforming youth."
Among medical groups that have supported such treatment are the American Academy of Pediatrics.
"AAP (the academy) policy states that youths who identify as transgender should have access to comprehensive, gender-affirming and developmentally appropriate health care that is provided in a safe and inclusive clinical space in close consultation with parents," said a post this month on the academy's website.
Issues about treatment of transgender youths have led to fights in states such as Alabama and Texas. Alabama Gov. Kay Ivey this month signed a measure that would make it a crime to provide treatment such as puberty-blocking medication and hormone-replacement therapy. The measure quickly drew a legal challenge.
The Florida Department of Health guidance said, in part, that people under age 18 "should not be prescribed puberty blockers or hormone therapy" and that gender "reassignment surgery should not be a treatment option for children or adolescents." It also said that "social gender transition should not be a treatment option for children or adolescents."
"The department crafted this guidance using published and peer-reviewed data that calls into question the motives of the federal HHS," the accompanying news release said. "Guidance of this magnitude requires a full, diligent understanding of the scientific evidence."
But the LGBTQ-advocacy group Equality Florida issued a statement that said the DeSantis administration "seeks to replace science and the safety of young people with political propaganda."
"The Florida Department of Health has released non-binding guidance opposing science-backed health care resources for parents of transgender children," the Equality Florida statement said. "This guidance demonizes life-saving, medically necessary care and asserts that the government, not parents, knows best when it comes to health care for our children. And, once again, DeSantis wants the government to intrude into doctors' offices to pander to extremists in service to his political ambitions."
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllMiami Firm Reaches $1.9M Settlement for Protester's Injuries, Pursues Class Action for Others
COVID-19 Death Suit Against Nursing Home Sent to State Court, 11th Circuit Affirms
Trending Stories
- 1The Key Moves in the Reshuffling German Legal Market as 2025 Dawns
- 2Social Media Celebrities Clash in $100M Lawsuit
- 3Federal Judge Sets 2026 Admiralty Bench Trial in Baltimore Bridge Collapse Litigation
- 4Trump Media Accuses Purchaser Rep of Extortion, Harassment After Merger
- 5Judge Slashes $2M in Punitive Damages in Sober-Living Harassment Case
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250